4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-24-105616
Director sold 11,016 shares at $91.31 ($1,005,871)
- Director acquired 11,016 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saad Mark E Director | 2024-09-11 | Option exercise 10b5-1 | +11,016 | $3.67 | $40,429 | 21,018 | D |
| Saad Mark E Director | 2024-09-11 | Sale 10b5-1 | −11,016 | $91.31 | $1,005,871 | 10,002 | D |
| Derivatives | |||||||
| Saad Mark E Director | 2024-09-11 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,016 | 0 | D | ||
| Open-market sales · 11,016 sh · avg $91.31 · $1,005,871 | |||||||
Loading xslF345X05/ownership.xml…